C. Henwood

Reliability of routine disc susceptibility testing by the British Society for Antimicrobial Chemotherapy (BSAC) method.

D. Livermore, D. James, A. Johnson, 2004, The Journal of antimicrobial chemotherapy.

Population structure and antibiotic resistance of Acinetobacter DNA group 2 and 13TU isolates from hospitals in the UK.

N. Woodford, D. Livermore, D. James, 2002, Journal of medical microbiology.

Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).

N. Woodford, D. Livermore, D. James, 2002, The Journal of antimicrobial chemotherapy.

Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group.

D. Livermore, D. James, A. Johnson, 2000, The Journal of antimicrobial chemotherapy.

Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test.

D. Livermore, D. James, M. Warner, 2001, The Journal of antimicrobial chemotherapy.

Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents.

D. Livermore, D. James, A. Johnson, 2003, The Journal of hospital infection.

In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles.

A. Charlett, D. Livermore, D. James, 2003, International Journal of Antimicrobial Agents.

Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK.

A. Johnson, M. Warner, L. Tysall, 2001, International journal of antimicrobial agents.